Cargando…
Management of rare side effects of peginterferon and ribavirin therapy during hepatitis C treatment: a case report
Cardiac arrhythmias and syncope are rare consequence of therapy with pegylated interferon. We report a 55-year-old Egyptian woman who developed palpitation and syncopal attacks twice within 3 months after starting therapy with pegylated interferon α2b and ribavirin for the treatment of chronic hepat...
Autores principales: | EL-Atrebi, Kamal, El-Bassyouni, Hala T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Cases Network Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2740062/ https://www.ncbi.nlm.nih.gov/pubmed/19829962 http://dx.doi.org/10.4076/1757-1626-2-7429 |
Ejemplares similares
-
Sexual Dysfunction in Males with Hepatitis C Virus: Relevance to Histopathologic Changes and Peginterferon Treatment
por: El-Atrebi, Kamal A., et al.
Publicado: (2011) -
Is peginterferon and ribavirin therapy effective in Korean patients with chronic hepatitis C?
por: Jung, Young Kul, et al.
Publicado: (2013) -
Cost-Efficacy Analysis of Peginterferon alfa-2b plus Ribavirin Compared With Peginterferon alfa-2a plus Ribavirin for the Treatment of Chronic Hepatitis C
por: Malone, Daniel C., et al.
Publicado: (2005) -
Peginterferon alpha and ribavirin combination therapy in patients with hepatitis C virus-related liver cirrhosis
por: Kim, Kyung Hoon, et al.
Publicado: (2011) -
Pretreatment prediction of the outcome of response-guided peginterferon-α and ribavirin therapy for chronic hepatitis C
por: Masaki, Naohiko, et al.
Publicado: (2014)